Skip to main content
. 2021 Feb 5;5(3):812–822. doi: 10.1182/bloodadvances.2020002971

Table 2.

SPR steady-state KD determinations (nM)

coh-VWF An101-VWF An84-VWF An63-VWF An70-VWF An88-VWF
Human FVIII 1.84 ± 0.19 2.35 ± 0.31 4.05 ± 0.14**** 5.47 ± 0.41**** 0.68 ± 0.15** 1.14 ± 0.06
An101-FVIII 1.68 ± 0.25 2.06 ± 0.28 3.27 ± 0.30**** 4.25 ± 0.30**** 0.88 ± 0.23* 1.13 ± 0.11
An84-FVIII 1.55 ± 0.09 1.87 ± 0.21 2.56 ± 0.23 2.90 ± 0.08 ** 1.08 ± 0.30 1.02 ± 0.22
An63-FVIII 2.15 ± 0.28 2.62 ± 0.39 4.49 ± 0.60**** 3.80 ± 0.29**** 0.95 ± 0.10* 1.71 ± 0.10
An70-FVIII 2.17 ± 0.29 2.67 ± 0.54 5.17 ± 0.33**** 4.03 ± 0.39**** 0.98 ± 0.02* 1.84 ± 0.13
An88-FVIII 0.96 ± 0.08* 1.01 ± 0.06 1.22 ± 0.27 1.17 ± 0.30 1.28 ± 0.29 0.77 ± 0.18**

SPR, surface plasmon resonance.

*

P < .05, **P < .005, ****P < .0001.